26 subscribers
Player FM ऐप के साथ ऑफ़लाइन जाएं!
Prof. Solange Peters, MD, PhD - Are We Closer to a Cure With Perioperative Immunotherapy in Resectable NSCLC? Latest Evidence, Current Conclusions, and Ongoing Questions in Clinical Care
Manage episode 443252426 series 103624
For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/AWU865. CME credit will be available until September 23, 2025.
Are We Closer to a Cure With Perioperative Immunotherapy in Resectable NSCLC? Latest Evidence, Current Conclusions, and Ongoing Questions in Clinical Care
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.
Disclosure information is available at the beginning of the video presentation.
245 एपिसोडस
Manage episode 443252426 series 103624
For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/AWU865. CME credit will be available until September 23, 2025.
Are We Closer to a Cure With Perioperative Immunotherapy in Resectable NSCLC? Latest Evidence, Current Conclusions, and Ongoing Questions in Clinical Care
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.
Disclosure information is available at the beginning of the video presentation.
245 एपिसोडस
सभी एपिसोड
×
1 Zachariah DeFilipp, MD, Betty K. Hamilton, MD - The Good, the Bad, and the GVHD: Leveraging Modern Therapeutics to Improve Post-Transplant Outcomes 57:40

1 Anna Kovalszki, MD, FAAAAI, Michael E. Wechsler, MD - Stories Behind the Science in EGPA: Updated Strategies for Diagnosis, Treatment, and Reducing the Steroid Burden in Patients 1:00:59

1 Professor Benjamin Solomon, MBBS, PhD, FRACP, FAHMS - ALK+ mNSCLC Care Compass: Taking Your Best Shot First—Selecting and Sequencing Targeted Therapy and Teaming Up to Achieve Long-Term Success 1:04:32

1 Michael E. Wechsler, MD - Overcoming Challenges in the Management of Severe Asthma: Expert Insights on Emerging Strategies to Close the Gaps to Optimal Care 1:02:55

1 Krish Patel, MD / Nirav Shah, MD, MS - The Innovation Intersection in B-Cell Cancers: Navigating Choices With Modern Targeted Strategies, Cellular Therapy, and HCT 55:31

1 Jacob Sands, MD - "Experts vs AI" ADC Challenge—Lung Cancer Edition: Interpreting the Evidence, Exploring Practicalities 47:34

1 Maissaa Janbain, MD, MSCR - Leveling the Standard of Care in Hemophilia A: Insights and Strategies for Developing Effective, Personalized Treatment Plans 50:52

1 MeiLan K. Han, MD, MS - Expert Insights on the Use of Targeted Biologic Therapy in Patients With COPD and Evidence of Type 2 Inflammation: Taking It on a Case-by-Case Basis 32:49

1 Joshua Sabari, MD - Modern Practice Principles in Lung Cancer—First Find the Targets, Then Treat With Precision: A Concise Guide for Biomarker Testing and EGFR-Targeted Therapy in NSCLC 21:41

1 Grzegorz (Greg) S. Nowakowski, MD, FASCO - Addressing Unmet Needs for Better Outcomes in DLBCL: Leveraging Prognostic Assessment and Off-the-Shelf Immunotherapy Strategies 16:54

1 Jessica Donington, MD - Mastering the Integration of Immunotherapy in Resectable NSCLC: Practical Considerations for Real-World Practice 58:31

1 Mara B. Antonoff, MD, FACS / Karen L. Reckamp, MD - Targeting Higher Standards in Resectable NSCLC: The Surgery-Oncology Coalition for Tailoring Care in EGFR and ALK TKI Therapy 53:25

1 David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches 47:14

1 Michelle Kittleson, MD, PhD / Senthil Selvaraj, MD, MS, MA - Don’t Fail Them Now: Bridging Diagnostic and Treatment Gaps in Transthyretin Cardiac Amyloidosis 59:21

1 Milind Desai, MD, MBA, FACC, FAHA, FESC - Remodeling Innovation: Applying Clinical Research and Real-World Experience With Cardiac Myosin Inhibition in HCM and Beyond 1:01:53
प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।